Jens Klotsche

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 22

Top Topics

Juvenile Idiopathic Arthritis

Systemic Sclerosis

Respiratory Syndrome Coronavirus

Top Venues

The Journal of rheumatology

Annals of the rheumatic diseases

Arthritis care & research

This page only lists publications with an associated author ORCID identifier.

Publications

Tatjana Welzel, Beate Zapf, Jens Klotsche, Özlem Satirer, Susanne M Benseler, Jasmin B Kuemmerle-Deschner
Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments. Journal of clinical medicine 13 (8) (2024)
Henriette Haney, Jens Klotsche, Martina Niewerth, Sandra Hansmann, Gabi Erbis, Christiane Reiser, Sebastian Jonas Saur, Paula Hoff, Eva Seipelt, Anna Maier, Susanne Schalm, Stefanie Tatsis, Ivan Foeldvari, Ina Koetter, Kirsten Minden
Assessing Competencies, Needs, and Satisfaction With the Transition From Pediatric to Adult Health Care in Rheumatology: Development and Validation of the Transition-KompAZ. The Journal of rheumatology (2024)
Malthe J Pedersen, Christian Høst, Stefan Nygaard Hansen, Jens Klotsche, Kirsten Minden, Bent Winding Deleuran, Bodil Hammer Bech
School Well-Being and Academic Performance of Children With Juvenile Idiopathic Arthritis: A National Register-Based Study. The Journal of rheumatology 51 (8) (2024)
Tatjana Welzel, Beate Zapf, Jens Klotsche, Özlem Satirer, Susanne M Benseler, Jasmin B Kuemmerle-Deschner
Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments. Journal of clinical medicine 13 (8) (2024)
Henriette Haney, Jens Klotsche, Martina Niewerth, Sandra Hansmann, Gabi Erbis, Christiane Reiser, Sebastian Jonas Saur, Paula Hoff, Eva Seipelt, Anna Maier, Susanne Schalm, Stefanie Tatsis, Ivan Foeldvari, Ina Koetter, Kirsten Minden
Assessing Competencies, Needs, and Satisfaction With the Transition From Pediatric to Adult Health Care in Rheumatology: Development and Validation of the Transition-KompAZ. The Journal of rheumatology (2024)
Malthe J Pedersen, Christian Høst, Stefan Nygaard Hansen, Jens Klotsche, Kirsten Minden, Bent Winding Deleuran, Bodil Hammer Bech
School Well-Being and Academic Performance of Children With Juvenile Idiopathic Arthritis: A National Register-Based Study. The Journal of rheumatology (2024)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Jens Klotsche, Kathryn S Torok, Ozgur Kasapcopur, Amra Adrovic, Maria Teresa Terreri, Ana Paula Sakamoto, Maria Katsicas, Flavio Sztajnbok, Edoardo Marrani, Alberto Sifuentes-Giraldo, Valda Stanevicha, Jordi Antón, Brian Feldmann, Mikhail Kostik, Dana Nemcova, Maria Jose Santos, Simone Appenzeller, Tadej Avcin, Cristina Battagliotti, Lillemor Berntson, Blanca Bica, Jürgen Brunner, Despina Eleftheriou, Liora Harel, Gerd Horneff, Tilmann Kallinich, Kirsten Minden, Susan Nielsen, Anjali Patwardhan, Nicola Helmus, Ivan Foeldvari
Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis. Journal of scleroderma and related disorders 8 (3) (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Ivan Foeldvari, Kathryn S Torok, Jens Klotsche, Jordi Antón, Patricia Cost Reis, Francesco Del Galdo, Christopher P Denton, Bernd Hinrichs, Suzanne C Li, Clare Pain, Clarissa Pilkington, Maurizio Cutolo, Ozgur Kasapcopur, Zsuzsanna H McMahan, Nicolino Ruperto, Vanessa Smith, Daniel E Furst
Proposed response parameters for 12 months drug trial in Juvenile Systemic Sclerosis. Results of the Hamburg International Consensus Meetings. Arthritis care & research (2023)
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik Nils Albach, Jens Klotsche, Veronika Scholz, Lara Maria Jeworowski, Tatjana Schwarz, Alexander Ten Hagen, Jan Zernicke, Victor Max Corman, Christian Drosten, Gerd-Rüdiger R Burmester, Robert Biesen
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases. Annals of the rheumatic diseases 81 (6) (2022)
Joeri W van Straalen, Lianne Kearsley-Fleet, Jens Klotsche, Sytze De Roock, Kirsten Minden, Arnd Heiligenhaus, Kimme L Hyrich, Joke H de Boer, Lovro Lamot, Alma N Olivieri, Romina Gallizzi, Elzbieta Smolewska, Enrique Faugier, Serena Pastore, Philip J Hashkes, Cristina N Herrera, Wolfgang Emminger, Rita Consolini, Nico M Wulffraat, Nicolino Ruperto, Joost F Swart, null null
Development and external validation of a model predicting new-onset chronic uveitis at different disease durations in juvenile idiopathic arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Jens Klotsche, Fredrik Nils Albach, Alexander Ten Hagen, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Florian Kurth, Leif-Erik Sander, Gerd-Rüdiger R Burmester, Florian Klein, Robert Biesen
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination. RMD open 8 (2) (2022)
Manuel Graf, Sae Lim von Stuckrad, Akinori Uruha, Jens Klotsche, Lydia Zorn-Pauly, Nadine Unterwalder, Thomas Buttgereit, Krusche Martin, Christian Meisel, Gerd-Rüdiger R Burmester, Falk Hiepe, Robert Biesen, Tilmann Kallinich, Werner Stenzel, Udo Schneider, Thomas Rose
SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies. RMD open 8 (1) (2022)
Karoline Walscheid, Kai Rothaus, Martina Niewerth, Jens Klotsche, Kirsten Minden, Arnd Heiligenhaus
Occurrence and Risk Factors of Uveitis in Juvenile Psoriatic Arthritis: Data From a Population-based Nationwide Study in Germany. The Journal of rheumatology 49 (7) (2022)
Laura J Montag, Gerd Horneff, Paula Hoff, Ariane Klein, Tilmann Kallinich, Ivan Foeldvari, Eva Seipelt, Stefanie Tatsis, M D Peer Aries, Martina Niewerth, Jens Klotsche, Kirsten Minden
Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational study. RMD open 8 (2) (2022)
Kirsten Minden, Jens Klotsche
Transition Between Treatments: What We Need to Know. The Journal of rheumatology 48 (8) (2021)
Jens Klotsche, Ariane Klein, Martina Niewerth, Paula Hoff, Daniel Windschall, Ivan Foeldvari, Johannes-Peter Haas, Gerd Horneff, Kirsten Minden
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis. Arthritis research & therapy 23 (1) (2021)
Ivan Foeldvari, Jens Klotsche, Ozgur Kasapcopur, Amra Adrovic, Maria Teresa Terreri, Ana Paula Sakamoto, Valda Stanevicha, Flavio Sztajnbok, Jordi Antón, Brian Feldman, Ekaterina Alexeeva, Maria Katsicas, Vanessa Smith, Tadej Avcin, Edoardo Marrani, Mikhail Kostik, Thomas Lehman, Walter-Alberto Sifuentes-Giraldo, Natalia Vasquez-Canizares, Simone Appenzeller, Mahesh Janarthanan, Monika Moll, Dana Nemcova, Anjali Patwardhan, Maria Jose Santos, Sujata Sawhney, Dieneke Schonenberg-Meinema, Cristina Battagliotti, Lillemor Berntson, Blanca Bica, Jürgen Brunner, Patricia Costa-Reis, Despina Eleftheriou, Liora Harel, Gerd Horneff, Daniela Kaiser, Tilmann Kallinich, Dragana Lazarevic, Kirsten Minden, Susan Nielsen, Farzana Nuruzzaman, Yosef Uziel, Nicola Helmus, Kathryn S Torok
Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort. www.juvenile-scleroderma.com. Arthritis care & research (2021)
Kirsten Minden, Gerd Horneff, Martina Niewerth, Eva Seipelt, Martin Aringer, Peer Aries, Ivan Foeldvari, Johannes-Peter Haas, Ariane Klein, Stefanie Tatsis, Klaus Tenbrock, Angela Zink, Jens Klotsche
Time of Disease-Modifying Antirheumatic Drug Start in Juvenile Idiopathic Arthritis and the Likelihood of a Drug-Free Remission in Young Adulthood. Arthritis care & research 71 (4) (2020)
Jens Klotsche, Kirsten Minden, Martina Niewerth, Gerd Horneff
Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA. Annals of the rheumatic diseases 77 (7) (2018)
Tobias Alexander, Ramona Sarfert, Jens Klotsche, Anja A Kühl, Andrea Rubbert-Roth, Hannes-Martin Lorenz, Jürgen Rech, Bimba F Hoyer, Qingyu Cheng, Aderajew Waka, Adriano Taddeo, Michael Wiesener, Georg Schett, Gerd-Rüdiger Burmester, Andreas Radbruch, Falk Hiepe, Reinhard E Voll
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus. Annals of the rheumatic diseases 74 (7) (2015)
Claudia Sengler, Jens Klotsche, Martina Niewerth, Ina Liedmann, Dirk Föll, Arnd Heiligenhaus, Gerd Ganser, Gerd Horneff, Johannes-Peter Haas, Kirsten Minden
The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort. RMD open 1 (1) (2015)
Jens Klotsche, Martina Niewerth, Johannes-Peter Haas, Hans-Iko Huppertz, Angela Zink, Gerd Horneff, Kirsten Minden
Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA). Annals of the rheumatic diseases 75 (5) (2015)